Last update 01 Nov 2024

Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cefalium
Target
5-HT1B receptor x 5-HT1D receptor x A1R x A2aR x COX x DRDs
Mechanism
5-HT1B receptor agonists(Serotonin 1b (5-HT1b) receptor agonists), 5-HT1D receptor agonists(Serotonin 1d (5-HT1d) receptor agonists), A1R antagonists(Adenosine A1 receptor antagonists)
+ [3]
Therapeutic Areas
Nervous System Diseases
Active Indication-
Inactive Indication
Migraine Disorders
Originator Organization
Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
Active Organization-
Inactive Organization
Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
Drug Highest PhaseSuspendedPhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC8H10N4O2
InChIKeyRYYVLZVUVIJVGH-UHFFFAOYSA-N
CAS Registry58-08-2
View All Structures (4)

Related

1
Clinical Trials associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
NCT02582996 / SuspendedPhase 3
National, Phase III, Multicenter, Randomized, Open, Parallel, to Evaluate the Efficacy, Safety and Superiority of Cefalium® Compared to the Tylenol® in the Treatment of Migraine Attacks
100 Clinical Results associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
Login to view more data
100 Translational Medicine associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
Login to view more data
100 Patents (Medical) associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
Login to view more data
1
Literatures (Medical) associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
01 Jan 2018RETINAL Cases & Brief Reports
CEFALIUM-INDUCED BILATERAL TRANSIENT MYOPIA, RETINAL FOLDS, AND FOCAL CHOROIDAL DELAY
100 Deals associated with Acetaminophen/Caffeine/DIHYDROERGOTAMINE MESYLATE/METOCLOPRAMIDE HYDROCHLORIDE
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Migraine DisordersPhase 3
BR
Aché Laboratórios Farmacêuticos SAAché Laboratórios Farmacêuticos SA
01 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free